Increased levels of interleukin-1β and soluble intercellular adhesion molecule-1 in cerebrospinal fluid of patients with subacute sclerosing panencephalitis

Journal of Infectious Diseases

Volumn 175, Issue 3, 1997, Pages 689-692

  Mehta, P D ^a   Kulczycki, J ^b   Mehta, S P ^b   Coyle, P K ^b   Wisniewski, H M ^b  

^a NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPATHOGENESIS; IMMUNOPATHOLOGY; MEASLES VIRUS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHOOL CHILD; SUBACUTE SCLEROSING PANENCEPHALITIS; TISSUE DISTRIBUTION;

EID: 0031035885     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/175.3.689     Document Type: Article

References (14)

1. ter Meulen V, Stephenson JR, Kreth HW. Subacute sclerosing panencephalitis. Comp Virol 1983;17:105-7.
2. Mehta PD, Thormar H, Kulczycki J, Wisniewski HM. Immune response in subacute sclerosing panencephalitis: Ann NY Acad Sci 1994;724:378-84.
3. Callard RE, Gearing AJH. The cytokine factsbook. London: Academic Press, 1994.
4. Gearing AJH, Newman W. Circulating adhesion molecules in disease. Immunol Today 1993;14:506-12.
5. Nagano I, Nakamura S, Yoshioka M, Onodera J, Kogure K, Itoyama Y. Expression of cytokines in brain lesions in subacute sclerosing panencephalitis. Neurology 1994;44:710-5.
6. Jabbour JT, Deunas DA, Modlin J. SSPE: clinical staging, course and frequency. Arch Neurol 1975;32:493-4.
7. Waage A, Halstensen A, Shalaby R, Brandtzaeg P, Kierulf P, Espevik T. Local production of tumor necrosis factor a, interleukin 1, and interleukin 6 in meningococcal meningitis: Relation to the inflammatory response. J Exp Med 1989;170:1859-67.
8. Hauser SL, Doolittle TH, Lincoln R, Brown RH, Dinarello CA. Cytokine accumulations in CSF of multiple sclerosis patients: frequent detection of interleukin-1 and tumor necrosis factor but not interleukin-6. Neurology 1990;40:1735-9.
9. Maimone D, Gregory S, Arnason BGW, Reder AT. Cytokine levels in the cerebrospinal fluid and serum of patients with multiple sclerosis. J Neuroimmunol 1991;32:67-74.
10. Franciotta DM, Grimaldi LME, Martino GV, et al. Tumor necrosis factor in serum and cerebrospinal fluid of patients with multiple sclerosis. Ann Neurol 1989;26:787-9.
11. Shaw CE, Dunbar PR, Macaulsy HA, Neale TJ. Measurement of immune markers in the serum and cerebrospinal fluid of multiple sclerosis patients during clinical remission. J Neurol 1995;242:53-8.
12. Droogan AG, McMillan SA, Douglas JP, Hawkins SA. Serum and cerebrospinal levels of soluble adhesion molecules in multiple sclerosis: predominant intrathecal release of vascular cell adhesion molecule-1. J Neuroimmunol 1996;64:185-91.
13. Dore-Duffy P, Newman W, Balabanov R, et al. Circulating, soluble adhesion proteins in cerebrospinal fluid and serum of patients with multiple sclerosis: correlation with clinical activity. Ann Neurol 1995;37:55-62.
14. Woodroofe MN. Cytokine production in the central nervous system. Neurology 1995;45:S6-10.